These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15673153)

  • 1. The genetic role in autosomal dominant polycystic kidney disease and nephrology clinical practice.
    Avery-Lynch M
    CANNT J; 2004; 14(4):26-9, 32-5; quiz 29-30, 35-6. PubMed ID: 15673153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
    Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
    Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
    Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
    Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
    BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKD2 gene mutation analysis in Korean autosomal dominant polycystic kidney disease patients using two-dimensional gene scanning.
    Chung W; Kim H; Hwang YH; Kim SY; Ko AR; Ro H; Lee KB; Lee JS; Oh KH; Ahn C
    Clin Genet; 2006 Dec; 70(6):502-8. PubMed ID: 17100995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease.
    Paterson AD; Wang KR; Lupea D; St George-Hyslop P; Pei Y
    Am J Kidney Dis; 2002 Jul; 40(1):16-20. PubMed ID: 12087556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis in PKD1 of Japanese autosomal dominant polycystic kidney disease patients.
    Inoue S; Inoue K; Utsunomiya M; Nozaki J; Yamada Y; Iwasa T; Mori E; Yoshinaga T; Koizumi A
    Hum Mutat; 2002 Jun; 19(6):622-8. PubMed ID: 12007219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKDB: Polycystic Kidney Disease Mutation Database--a gene variant database for autosomal dominant polycystic kidney disease.
    Gout AM; Martin NC; Brown AF; Ravine D
    Hum Mutat; 2007 Jul; 28(7):654-9. PubMed ID: 17370309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
    Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
    J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical genetics for autosomal dominant polycystic kidney disease.
    Pei Y
    Nephron Clin Pract; 2011; 118(1):c19-30. PubMed ID: 21071968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic heterogeneity and phenotypes of autosomal dominant polycystic kidney disease in Chinese Han nationality].
    Zhang WL; Mei CL
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1516-21. PubMed ID: 16854275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of autosomal dominant polycystic kidney disease.
    Bennett WM; Elzinga LW
    Kidney Int Suppl; 1993 Jul; 42():S74-9. PubMed ID: 8361135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variable progression of autosomal dominant polycystic kidney disease: genetic and molecular counterparts].
    Devuyst O
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S104-8. PubMed ID: 17373208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
    Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
    Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of nephrologists and patients about autosomal dominant polycystic kidney disease (ADPKD).
    Rosenberg EE; Tannenbaum TN; Miller SD; Lamothe EM; Rosenblatt DS
    Clin Invest Med; 1992 Oct; 15(5):440-4. PubMed ID: 1458717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "An evil heritage": interview study of pain and autosomal dominant polycystic kidney disease.
    Heiwe S; Bjuke M
    Pain Manag Nurs; 2009 Sep; 10(3):134-41. PubMed ID: 19706350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease: a case study.
    Phillips A
    Nephrol Nurs J; 2009; 36(1):41-7. PubMed ID: 19271623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.